I picked up some THRX a little bit ago. Stock seems undervalued given the pipeline, strong and favorable partnership with GSK and a positive decision by the fda panel for their copd drug that could be a billion dollar money maker
i have a decent holding here. i mentioned it on the other board to buy @23 4 or 5 weeks ago.the idiots ranted cause i said gsk owns 27%.to many idiots and fools and haters there.good luck with thrx.i think this stock will make us a very good profit.good luck zwerp
I bought some today, as welll and then I read this...explains the price decline. ugh
12:31 PM EDT, 04/24/2013 (MidnightTrader) -- Theravance (THRX
was downgraded to Market Perform from Outperform at Bernstein.
Shares are down $3.93% at $30.54 with a 52-week range of $17.06 - $33.31
Price: 30.54, Change: -1.25, Percent Change: -3.93